Norden Group’s DexCom DXCM Stock Holding History

Norden Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,791	Closed	-$855K	–	595
2025 Q2	$855K	Buy	9,791 +1,268	+15%	+$99.4K	0.09%	216
2025 Q1	$582K	Sell	8,523 -335	-4%	-$27.3K	0.07%	279
2024 Q4	$689K	Buy	+8,858	New	+$656K	0.08%	270

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norden Group's DXCM Position: Q3 2025 in Review

Norden Group sold out of DexCom (DXCM) in Q3 2025, closing a stake of 9,791 shares — an estimated $855K sold.

Norden Group first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $855K in Q2 2025. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Norden Group reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Norden Group sold 9,791 DexCom shares in Q3 2025, an estimated $855K.
Norden Group first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
Norden Group's DexCom position peaked at $855K in Q2 2025.
910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Norden Group's 13F filing for Q3 2025, filed 15 Oct 2025.